Ruxolitinib: A new hope for ventilator‐induced diaphragm dysfunction
Ruxolitinib: A new hope for ventilator‐induced diaphragm dysfunction
About this item
Full title
Author / Creator
Publisher
England: Wiley Subscription Services, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: Wiley Subscription Services, Inc
Subjects
More information
Scope and Contents
Contents
Aim
Mechanical ventilation (MV) results in diminished diaphragm size and strength, termed ventilator‐induced diaphragm dysfunction (VIDD). VID increases dependence, prolongs weaning, and increases discharge mortality rates. The Janus kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway is implicated in VIDD, upregulated f...
Alternative Titles
Full title
Ruxolitinib: A new hope for ventilator‐induced diaphragm dysfunction
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_855231
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_855231
Other Identifiers
ISSN
1748-1708,1748-1716
E-ISSN
1748-1716
DOI
10.1111/apha.14128
